according to the American Cancer Society. Dostarlimab—known generically as Jemperli—was developed by GSK in partnership with the biotech firm AnaptysBio in 2014, as the company expanded into ...

The American Cancer Society plans to name an interim CEO by the end of the year and conduct a national search for a permanent ...

according to the American Cancer Society. GSK, in its news release, cited statistics that the five-year survival rate of extensive-stage small cell lung cancer is 3% and that the median overall ...

GlaxoSmithKline (GSK) plans to take a blood cancer antibody ... pre-treated multiple myeloma patients, presented at the American Society for Hematology (ASH) conference, was therefore hotly ...

GSK announced a major breakthrough concerning cancer therapy. A drug called Jemperli (dostarlimab) showed impressive results ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

The American Cancer Society will host an inaugural event celebrating the accomplishments and contributions of local women.

Orphan Drug Designation in Soft Tissue Sarcomas Expands Company’s Potential to Address Cancers with High Unmet Medical Need CHICAGO and FORT WORTH, Texas, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Actuate ...

Drug maker GSK plc (GSK, GSK.L) announced Tuesday that Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple ...

Atomic Golf Las Vegas is thrilled to announce their partnership with the American Cancer Society, beginning September 19. The ...

Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...